vs

Side-by-side financial comparison of BRINKER INTERNATIONAL, INC (EAT) and Steris (STE). Click either name above to swap in a different company.

Steris is the larger business by last-quarter revenue ($1.5B vs $1.5B, roughly 1.0× BRINKER INTERNATIONAL, INC). Steris runs the higher net margin — 12.9% vs 8.8%, a 4.0% gap on every dollar of revenue. On growth, Steris posted the faster year-over-year revenue change (9.2% vs 6.9%). Steris produced more free cash flow last quarter ($199.5M vs $155.2M). Over the past eight quarters, Steris's revenue compounded faster (15.8% CAGR vs 13.9%).

Brinker International, Inc. is an American multinational hospitality industry company that owns Chili's and Maggiano's Little Italy restaurant chains. Founded in 1975 and based in Dallas, Texas, Brinker currently owns, operates, or franchises 1,672 restaurants under the names Chili's Grill & Bar and Maggiano's Little Italy worldwide.

Steris plc is an American-Irish-based medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, and has been legally registered in Dublin, Ireland, for tax purposes since 2018. Previously the company was registered in the United Kingdom from 2014 to 2018.

EAT vs STE — Head-to-Head

Bigger by revenue
STE
STE
1.0× larger
STE
$1.5B
$1.5B
EAT
Growing faster (revenue YoY)
STE
STE
+2.2% gap
STE
9.2%
6.9%
EAT
Higher net margin
STE
STE
4.0% more per $
STE
12.9%
8.8%
EAT
More free cash flow
STE
STE
$44.3M more FCF
STE
$199.5M
$155.2M
EAT
Faster 2-yr revenue CAGR
STE
STE
Annualised
STE
15.8%
13.9%
EAT

Income Statement — Q2 FY2026 vs Q3 FY2026

Metric
EAT
EAT
STE
STE
Revenue
$1.5B
$1.5B
Net Profit
$128.5M
$192.9M
Gross Margin
43.8%
Operating Margin
11.6%
18.3%
Net Margin
8.8%
12.9%
Revenue YoY
6.9%
9.2%
Net Profit YoY
8.4%
11.2%
EPS (diluted)
$2.86
$1.96

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EAT
EAT
STE
STE
Q4 25
$1.5B
$1.5B
Q3 25
$1.3B
$1.5B
Q2 25
$1.5B
$1.4B
Q1 25
$1.4B
$1.5B
Q4 24
$1.4B
$1.4B
Q3 24
$1.1B
$1.3B
Q2 24
$1.2B
$1.3B
Q1 24
$1.1B
$1.1B
Net Profit
EAT
EAT
STE
STE
Q4 25
$128.5M
$192.9M
Q3 25
$99.5M
$191.9M
Q2 25
$107.0M
$177.4M
Q1 25
$119.1M
$145.7M
Q4 24
$118.5M
$173.5M
Q3 24
$38.5M
$150.0M
Q2 24
$57.3M
$145.4M
Q1 24
$48.7M
$-1.4M
Gross Margin
EAT
EAT
STE
STE
Q4 25
43.8%
Q3 25
44.2%
Q2 25
45.1%
Q1 25
43.3%
Q4 24
44.5%
Q3 24
43.6%
Q2 24
44.7%
Q1 24
40.2%
Operating Margin
EAT
EAT
STE
STE
Q4 25
11.6%
18.3%
Q3 25
8.7%
18.2%
Q2 25
9.8%
17.7%
Q1 25
11.0%
14.6%
Q4 24
11.5%
17.9%
Q3 24
5.0%
16.5%
Q2 24
6.1%
14.5%
Q1 24
6.2%
22.0%
Net Margin
EAT
EAT
STE
STE
Q4 25
8.8%
12.9%
Q3 25
7.4%
13.1%
Q2 25
7.3%
12.8%
Q1 25
8.4%
9.8%
Q4 24
8.7%
12.7%
Q3 24
3.4%
11.3%
Q2 24
4.7%
11.4%
Q1 24
4.3%
-0.1%
EPS (diluted)
EAT
EAT
STE
STE
Q4 25
$2.86
$1.96
Q3 25
$2.17
$1.94
Q2 25
$2.31
$1.79
Q1 25
$2.56
$1.48
Q4 24
$2.61
$1.75
Q3 24
$0.84
$1.51
Q2 24
$1.22
$1.46
Q1 24
$1.08
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EAT
EAT
STE
STE
Cash + ST InvestmentsLiquidity on hand
$15.0M
$423.7M
Total DebtLower is stronger
$451.3M
$1.9B
Stockholders' EquityBook value
$379.3M
$7.2B
Total Assets
$2.7B
$10.6B
Debt / EquityLower = less leverage
1.19×
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EAT
EAT
STE
STE
Q4 25
$15.0M
$423.7M
Q3 25
$33.6M
$319.2M
Q2 25
$18.9M
$279.7M
Q1 25
$17.5M
$171.7M
Q4 24
$14.8M
$155.2M
Q3 24
$16.2M
$172.2M
Q2 24
$64.6M
$198.3M
Q1 24
$15.5M
$207.0M
Total Debt
EAT
EAT
STE
STE
Q4 25
$451.3M
$1.9B
Q3 25
$525.8M
$1.9B
Q2 25
$426.0M
$1.9B
Q1 25
$518.3M
$1.9B
Q4 24
$652.0M
$2.0B
Q3 24
$806.9M
$2.2B
Q2 24
$786.3M
$2.2B
Q1 24
$818.5M
$3.1B
Stockholders' Equity
EAT
EAT
STE
STE
Q4 25
$379.3M
$7.2B
Q3 25
$343.9M
$7.0B
Q2 25
$370.9M
$7.0B
Q1 25
$259.0M
$6.6B
Q4 24
$131.5M
$6.4B
Q3 24
$12.7M
$6.6B
Q2 24
$39.4M
$6.4B
Q1 24
$-46.7M
$6.3B
Total Assets
EAT
EAT
STE
STE
Q4 25
$2.7B
$10.6B
Q3 25
$2.7B
$10.4B
Q2 25
$2.7B
$10.4B
Q1 25
$2.6B
$10.1B
Q4 24
$2.6B
$10.0B
Q3 24
$2.5B
$10.2B
Q2 24
$2.6B
$10.1B
Q1 24
$2.5B
$11.1B
Debt / Equity
EAT
EAT
STE
STE
Q4 25
1.19×
0.27×
Q3 25
1.53×
0.27×
Q2 25
1.15×
0.27×
Q1 25
2.00×
0.29×
Q4 24
4.96×
0.32×
Q3 24
63.54×
0.33×
Q2 24
19.96×
0.35×
Q1 24
0.50×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EAT
EAT
STE
STE
Operating Cash FlowLast quarter
$218.9M
$298.2M
Free Cash FlowOCF − Capex
$155.2M
$199.5M
FCF MarginFCF / Revenue
10.7%
13.3%
Capex IntensityCapex / Revenue
4.4%
6.6%
Cash ConversionOCF / Net Profit
1.70×
1.55×
TTM Free Cash FlowTrailing 4 quarters
$455.9M
$917.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EAT
EAT
STE
STE
Q4 25
$218.9M
$298.2M
Q3 25
$120.8M
$287.8M
Q2 25
$186.0M
$420.0M
Q1 25
$212.0M
$260.8M
Q4 24
$218.2M
$332.8M
Q3 24
$62.8M
$250.7M
Q2 24
$141.5M
$303.7M
Q1 24
$130.1M
$254.8M
Free Cash Flow
EAT
EAT
STE
STE
Q4 25
$155.2M
$199.5M
Q3 25
$62.2M
$201.3M
Q2 25
$106.1M
$326.4M
Q1 25
$132.4M
$189.9M
Q4 24
$168.9M
$243.6M
Q3 24
$6.3M
$148.8M
Q2 24
$83.5M
$195.7M
Q1 24
$78.7M
$163.3M
FCF Margin
EAT
EAT
STE
STE
Q4 25
10.7%
13.3%
Q3 25
4.6%
13.8%
Q2 25
7.3%
23.5%
Q1 25
9.3%
12.8%
Q4 24
12.4%
17.8%
Q3 24
0.6%
11.2%
Q2 24
6.9%
15.3%
Q1 24
7.0%
14.6%
Capex Intensity
EAT
EAT
STE
STE
Q4 25
4.4%
6.6%
Q3 25
4.3%
5.9%
Q2 25
5.5%
6.7%
Q1 25
5.6%
4.8%
Q4 24
3.6%
6.5%
Q3 24
5.0%
7.7%
Q2 24
4.8%
8.4%
Q1 24
4.6%
8.2%
Cash Conversion
EAT
EAT
STE
STE
Q4 25
1.70×
1.55×
Q3 25
1.21×
1.50×
Q2 25
1.74×
2.37×
Q1 25
1.78×
1.79×
Q4 24
1.84×
1.92×
Q3 24
1.63×
1.67×
Q2 24
2.47×
2.09×
Q1 24
2.67×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EAT
EAT

Chilis Restaurants$1.3B91%
Maggianos Restaurants$134.9M9%
Franchise Revenues$13.4M1%

STE
STE

Servicerevenues$404.7M27%
Consumablerevenues$387.1M26%
Applied Sterilization Technologies$286.6M19%
Capitalequipmentrevenues$272.1M18%
Life Science$145.8M10%

Related Comparisons